Cannula Market Size, Share & Trends Analysis Report By Product (Cardiac, Dermatology, Nasal, And Others), By Type, By Material, By Size, By Region, And Segment Forecasts, 2022 - 2030

Report Overview

The global cannula market was valued at USD 158.4 million in 2021 and is anticipated to register a CAGR of 7.3% during the forecast period. The increase in demand for minimally invasive surgeries, the rise in the number of surgeries among the geriatric population, and the significant increase in the prevalence of chronic lifestyle-related diseases such as diabetes and cardiovascular diseases are the primary factors that are driving the growth of the cannula market. In addition, factors such as government initiatives to provide primary healthcare services at affordable rates and increase awareness regarding chronic diseases are also anticipated to further help the market grow significantly during the forecast period. 

The COVID-19 pandemic affected every aspect of human life. The economic, social, and financial aspects were affected in the majority of countries across the globe. The pandemic also led to major loss of life and disrupted the manufacturing and R&D activities. The restrictions and lockdowns led to severe disruption of the supply chain leading to a shortage of certain products. Many markets faced a drastic fall in sales due to the pandemic. On the other hand, certain markets experienced a sudden surge in sales during the pandemic. 

The market experienced a mixed impact during the pandemic. While there was a significant surge in demand for nasal cannula for the treatment of COVID-19 patients, the dermatology segment experienced a temporary drop in sales due to the postponement of elective surgeries. However, the dermatology segment recovered during the second half of the pandemic.

With a large population being infected with the COVID-19 virus, it can be projected that there could be a rise in respiratory diseases in the future. This is because the virus poses a great threat to the respiratory system. Moreover, with the opening up of economies and the world moving towards normalcy, the market is projected to experience lucrative growth during the forecast period. 

Minimally invasive surgeries are gaining popularity in the healthcare industry. There has been a rapid increase in the preference for minimally invasive surgeries for the treatment of cardiovascular diseases. This is due to the fact that minimally invasive surgeries cause less surgical trauma and result in a better aesthetic appearance. It offers advantages such as smaller incisions, minimized infection risks, smaller scars, a lesser amount of bleeding, and lesser pain & trauma. Thus, this is leading to an increased preference for minimally invasive surgeries which in turn is expected to boost the growth of the cannula market. 

Product Insights

Based on product, the cannula market is segmented into cardiac (arterial, venous, cardioplegia, and others) dermatology, nasal, and others. The cardiac segment held the largest market share in 2021. This is attributed to the high prevalence of cardiovascular diseases. Factors such as increasing shift toward a sedentary lifestyle, consumption of processed foods, and reduced amounts of physical activities are leading to a rise in the prevalence of cardiovascular disease. In addition, an increase in the geriatric population that is at higher risk of developing these diseases is also contributing to a significant rise in cardiovascular diseases. Thus, the rise in the prevalence of cardiovascular diseases is the major factor responsible for the dominance of the cardiac segment in the cannula market.

The dermatology segment is expected to administer significant growth during the forecast period. This is due to the increasing use of microcannula to avoid complications during and after procedures. Moreover, there is a significant rise in the number of cosmetic surgeries being carried out which is anticipated to further boost the demand for the dermatology segment. According to a research paper published in 2021, every year providers carry out more than 15 million cosmetic surgery procedures in the U.S. Thus, an increase in penetration of MIS is expected to gain segment growth during the forecast period. 

Type Insights

Based on type, the market is fragmented into neonatal cannulae, straight cannulae, winged cannulae, a wing with port, and winged with stop cork. The straight cannulae segment dominated the market with the highest market share in 2021. This is due to its design which makes it simpler to use. The product’s extra-sharp needle makes it easier to insert as well. Therefore, these types of cannulae are used in cardiac surgeries to avoid any mishaps and cut down any unnecessary delay that may lead to stretching the entire process. 

On the other hand, neonatal cannulae are expected to register maximum growth with the highest CAGR during the forecast period. The primary factor contributing to the growth of this segment is the increase in the prevalence of respiratory problems among neonates. The soft and flexible nature of neonatal cannulae makes them highly suitable for use in high flow oxygen therapy for newborns. According to a research paper published by the National Library of Medicine, in 2016, 33.3% of all neonatal admissions at >28 weeks’ gestation, excluding infants with syndromes and those with congenital or surgical conditions, had respiratory conditions as their primary reason for admission.

Material Insights

Based on material, the market is segmented into plastic, metal, and silicone. The plastic segment held the highest market share in 2021 due to its increased adoption rate in both in-patient and out-patient procedures. Most plastic cannulas are translucent and allow surgeons to visualize instrumentation & sutures passing through the cannula in shoulder arthroscopy. Thus, making it suitable for using it in maximum procedures which are leading to its dominance throughout the forecast period. 

However, the silicone segment is anticipated to experience maximum growth during the forecast period. This is attributed to the increasing usage of silicone cannulas in oxygen therapies, to ensure the continuous supply of oxygen to patients during surgery and for people suffering from respiratory disorders. Moreover, silicone cannulas are soft and flexible which makes them a preferred choice for application among healthcare professionals and patients.

Size Insights

Based on size, the market is segmented into 14G,16G,18G, 20G, 22G, 24G, and 26G. Different sized cannulas are represented by different colors. The 18G size accounted for the highest market share in 2021 and this trend is expected to continue throughout the forecast period. This is because the 18G size cannula is most widely used in hospitals for adults as well as adolescents. 18G cannulas are used to infuse blood products and deliver medications. These cannulas aim for quick blood transfusion. Moreover, these are also used for computed tomography/pulmonary embolism protocols or other testing that needs large IV sizes. 

The 22G size cannulas are expected to experience the highest growth growing at a significant CAGR during the forecast period. This can be attributed to its small gauge size which allows a faster flow of fluid in patients with complicated veins. According to a research study published in the Journal of Vascular Access in 2018, the majority of patients are treated successfully with one long peripheral cannula for the duration of their treatment without the need for further cannulation.

End-use Insights

Based on end-use, the market is classified into hospitals, ambulatory surgical centers, and others. The others segment includes blood banks, research centers, and pathology labs. The hospitals segment held the maximum market share in 2021. This is due to the rise in hospitalization rate for a variety of causes and treatments. Cannulas are used in a wide variety of specialty departments in the hospitals including orthopedic surgery, cardiovascular surgery, neurology, gynecology, general surgery, oxygen therapy, dermatology, and many more. 

Ambulatory surgical centers are projected to witness the fastest growth throughout the forecast period. Ambulatory surgical centers are modern healthcare facilities that offer same-day surgical care, along with preventive and diagnosis procedures. Thus, there is a rise in the shift towards ambulatory surgical centers to undergo treatment and avoid hospitalization. This in turn is leading to a rise in the number of ambulatory surgical centers. Currently, there are more than 9,280 active ambulatory surgical centers in the U.S. 

Regional Insights

North America dominated the market with the highest market share in 2021. This is due to the availability of advanced healthcare facilities in the region and the presence of dominant market players. In addition, the increasing prevalence of lifestyle diseases in the region is also a major factor in its dominance. Other factors such as greater awareness about minimally invasive surgeries and the increasing adoption rate of cosmetic surgeries in this region are further driving the growth of the market in this region. According to the American Society of Plastic Surgeons, about 16.7 billion USD was spent on cosmetic procedures in 2020 in the U.S.

Asia Pacific is expected to experience lucrative growth during the forecast period owing to a drastic rise in the geriatric population in the region which creates a massive patient pool with individuals suffering from chronic diseases such as cardiovascular diseases and diabetes. Moreover, the increasing efforts by the government to introduce favorable policies to transform the healthcare sector, especially in the rural areas is further expected to boost the growth of the market in this region.

Key Players & Market Share Insights

Key manufacturers in the market are focusing on launching new products in the market that will enable them to have a strong portfolio which will strengthen their position in the market. For instance, in May 2020, Medtronic announced the U.S. launch of Kyphon Assist Directional Cannula for balloon kyphoplasty. The market players are also focusing on market consolidation activities such as acquisitions and strategic partnerships which will help them to hold a dominant position in the market. Some of the major players operating in the cannula market are:

• Medtronic

• Becton Dickinson (BD)

• Edward Lifesciences

• LivaNova

• Smiths Medical

• Boston Scientific Corporation 

Cannula Market Report Scope

Segments covered in the report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Grand View Research has segmented the global cannula market based on technology, product, application, end-use, therapeutic area, and region:

• Product Outlook (Revenue in USD Million; 2017 - 2030)

  • Cardiac

    • Arterial

    • Venous

    • Cardioplegia

    • Femmoral

  • Dermatology

  • Nasal

  • Others

• Type Outlook (Revenue in USD Million; 2017 - 2030)

  • Neonatal cannulae

  • Straight cannulae

  • Winged cannulae

  • Wing with port

  • Winged with stop cork

• Material Outlook (Revenue in USD Million; 2017 - 2030)

  • Plastic

  • Metal

  • Silicone

• Size Outlook (Revenue in USD Million; 2017 - 2030)

  • 14G

  • 16G

  • 18G

  • 20G

  • 22G

  • 24G

  • 26G

• End-use Outlook (Revenue in USD Million; 2017 - 2030)

  • Hospital

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue in USD Million; 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Singapore

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • Saudi Arabia

    • South Africa

    • UAE